3rd Apr 2008 07:01
Sinclair Pharma PLC03 April 2008 Sinclair Pharma plc Director's Share Dealing 2 April 2008. Godalming, UK. Sinclair Pharma plc (LSE: SPH) ("Sinclair" or the"Company") announces that it has been informed that on 2 April 2008 certaindirectors of the Company, purchased Ordinary Shares of 1 pence each in theCompany. Dr. Michael Flynn purchased 1,000 shares at 40.15p, and Sookja Flynn, wife ofDr. Flynn, purchased 540,259 shares at an average price of 38.30p. Michael Flynnnow has an interest in 10,048,259 shares representing approximately 10.7% of theissued share capital of the Company. In addition, Jerry Randall purchased 250,000 shares at 38.25p taking his holdingto 785,000 shares representing approximately 0.84% of the issued share capitalof the Company. For further information please contact: Sinclair Pharma plc Tel: +44 (0) 1483 410 600Dr Michael Flynn, CEOJerry Randall, CFO Notes to Editors: About Sinclair Pharma Plc www.sinclairpharma.com Sinclair Pharma plc is an international specialty pharmaceutical company. Ithas a growing sales and marketing operation that is already present in France,Italy, UK, Spain and Portugal, and a complementary marketing partner networkthat spans more than 65 countries. Sinclair has proven expertise in acquiring or developing commercially attractiveand undervalued products, registering these products and bringing them to marketwithin a short time frame. The company focuses on niche therapeutic areas andits current portfolio includes products for dermatological conditions and oralhealth. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Sinclair Pharma